Citations (42)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Yanting Nie, Yiling Ding & Mengyuan Yang. (2020) GRHL2 Upregulation Predicts a Poor Prognosis and Promotes the Resistance of Serous Ovarian Cancer to Cisplatin. OncoTargets and Therapy 13, pages 6303-6314.
Read now
Read now
Zhenhua Hu, Mingbo Cai, Ying Zhang, Lingling Tao & Ruixia Guo. (2020) miR-29c-3p inhibits autophagy and cisplatin resistance in ovarian cancer by regulating FOXP1/ATG14 pathway. Cell Cycle 19:2, pages 193-206.
Read now
Read now
Khalid El Bairi, Mariam Amrani, Abdul Hafeez Kandhro & Said Afqir. (2017) Prediction of therapy response in ovarian cancer: Where are we now?. Critical Reviews in Clinical Laboratory Sciences 54:4, pages 233-266.
Read now
Read now
Gordon Greville, Amanda McCann, Pauline M. Rudd & Radka Saldova. (2016) Epigenetic regulation of glycosylation and the impact on chemo-resistance in breast and ovarian cancer. Epigenetics 11:12, pages 845-857.
Read now
Read now
Alfonso Duenas-Gonzalez, José L. Medina-Franco, Alma Chavez-Blanco, Guadalupe Dominguez-Gomez & Eli Fernández-de Gortari. (2016) Developmental DNA methyltransferase inhibitors in the treatment of gynecologic cancers. Expert Opinion on Pharmacotherapy 17:3, pages 323-338.
Read now
Read now
Articles from other publishers (37)
Ashley Suris, Yubin Zhou & Yun Huang. 2024. Comprehensive Precision Medicine. Comprehensive Precision Medicine
96
111
.
Nian-nian Li, Deng-xing Lun, Ningning Gong, Gang Meng, Xin-ying Du, He Wang, Xiangxiang Bao, Xin-yang Li, Ji-wu Song, Kewei Hu, Lala Li, Si-ying Li, Wenbo Liu, Wanping Zhu, Yunlong Zhang, Jikai Li, Ting Yao, Leming Mou, Xiaoqing Han, Furong Hao, Lei Wang, Bin Liu, Yongcheng Hu, Lin Liu, Hongguang Zhu, Yuyun Wu & Bin Liu. (2023) Targeting the chromatin structural changes of antitumor immunity. Journal of Pharmaceutical Analysis.
Crossref
Crossref
Ahmad Saburi, Mohammad Saeed Kahrizi, Navid Naghsh, Hasti Etemadi, Ahmet İlhan, Ali Adili, Shadi Ghoreishizadeh, Rozita Tamjidifar, Morteza Akbari & Gülinnaz Ercan. (2022) A comprehensive survey into the role of microRNAs in ovarian cancer chemoresistance; an updated overview. Journal of Ovarian Research 15:1.
Crossref
Crossref
Lin Zhao, Hongjie Guo, Xi Chen, Wenxin Zhang, Qiaojun He, Ling Ding & Bo Yang. (2022) Tackling drug resistance in ovarian cancer with epigenetic targeted drugs. European Journal of Pharmacology 927, pages 175071.
Crossref
Crossref
Hui Li, Yuansheng Lei, Shuangxue Li, Feng Li & Jieyun Lei. (2022) MicroRNA-20a-5p inhibits the autophagy and cisplatin resistance in ovarian cancer via regulating DNMT3B-mediated DNA methylation of RBP1. Reproductive Toxicology 109, pages 93-100.
Crossref
Crossref
Hong Zheng, Yunong Gao, Hongyan Guo, Li Li, Qingshui Li, Heng Cui, An Lin, Lixin Sun, Yuanjing Hu, Shan Kang, Wei Duan, Lingya Pan, Shuzhen Wang, Yingjie Yang, Yunxia Li, Weimin Kong, Yang Xiang, Xiaofei Tian, Bin Ling, Chunfang Ha & Wenpei Bai. (2021) Real-world Experience of Olaparib Treatment in Patients with Ovarian Cancer: A Chinese Multicenter Study. Molecular Cancer Therapeutics 20:9, pages 1735-1742.
Crossref
Crossref
Megan H Trager, Bindeshwar Sah, Zhongming Chen & Liang Liu. (2021) Control of Breast Cancer Pathogenesis by Histone Methylation and the Hairless Histone Demethylase. Endocrinology 162:8.
Crossref
Crossref
Dong-hai Li, Xiao-hui Du, Ming Liu & Rui Zhang. (2021) A 10-gene-methylation-based signature for prognosis prediction of colorectal cancer. Cancer Genetics 252-253, pages 80-86.
Crossref
Crossref
Lanbo Zhao, Sijia Ma, Linconghua Wang, Yiran Wang, Xue Feng, Dongxin Liang, Lu Han, Min Li & Qiling Li. (2021) A polygenic methylation prediction model associated with response to chemotherapy in epithelial ovarian cancer. Molecular Therapy - Oncolytics 20, pages 545-555.
Crossref
Crossref
Kevin DzoboChelene GanzNicholas Ekow ThomfordDimakatso Alice Senthebane. (2021) Cancer Stem Cell Markers in Relation to Patient Survival Outcomes: Lessons for Integrative Diagnostics and Next-Generation Anticancer Drug Development. OMICS: A Journal of Integrative Biology 25:2, pages 81-92.
Crossref
Crossref
Emily M. Miller, Timothy M. Samec & Angela A. Alexander-Bryant. (2021) Nanoparticle delivery systems to combat drug resistance in ovarian cancer. Nanomedicine: Nanotechnology, Biology and Medicine 31, pages 102309.
Crossref
Crossref
Nirupama Sabnis, Ezek Mathew, Akpedje Dossou, Amy Zheng, Bhavani Nagarajan, Rafal Fudala & Andras G. Lacko. 2021. Overcoming Drug Resistance in Gynecologic Cancers. Overcoming Drug Resistance in Gynecologic Cancers
77
126
.
Luna Acharya, Hariharasudan Mani, Aman Ullah, Sana Hussain, Saeed Ali & Sarfraz Ahmad. 2021. Overcoming Drug Resistance in Gynecologic Cancers. Overcoming Drug Resistance in Gynecologic Cancers
49
75
.
Luisa Matos do Canto, Mateus Camargo Barros-Filho, Cláudia Aparecida Rainho, Diogo Marinho, Bruna Elisa Catin Kupper, Maria Dirlei Ferreira de Souza Begnami, Cristovam Scapulatempo-Neto, Birgitte Mayland Havelund, Jan Lindebjerg, Fabio Albuquerque Marchi, Jan Baumbach, Samuel Aguiar Jr.Silvia Regina Rogatto. (2020) Comprehensive Analysis of DNA Methylation and Prediction of Response to NeoadjuvantTherapy in Locally Advanced Rectal Cancer. Cancers 12:11, pages 3079.
Crossref
Crossref
Daniela Matei & Kenneth P. Nephew. (2020) Epigenetic Attire in Ovarian Cancer: The Emperor's New Clothes. Cancer Research 80:18, pages 3775-3785.
Crossref
Crossref
Shiyan Chen, Xiaoxia Wang, Jin Yuan, Cui Deng, Xueman Xie & Jiali Kang. (2020) Reduced levels of actin gamma 1 predict poor prognosis in ovarian cancer patients. Journal of Obstetrics and Gynaecology Research 46:9, pages 1827-1834.
Crossref
Crossref
Kevin Dzobo, Dimakatso Alice Senthebane, Chelene Ganz, Nicholas Ekow Thomford, Ambroise Wonkam & Collet Dandara. (2020) Advances in Therapeutic Targeting of Cancer Stem Cells within the Tumor Microenvironment: An Updated Review. Cells 9:8, pages 1896.
Crossref
Crossref
Alba Mota, Sara S Oltra & Gema Moreno-Bueno. (2020) Insight updating of the molecular hallmarks in ovarian carcinoma. European Journal of Cancer Supplements 15, pages 16-26.
Crossref
Crossref
Liya Qiu, Jiakun Wang, Mei Chen, Fengyun Chen & Wenluo Tu. (2020) Exosomal microRNA‑146a derived from mesenchymal stem cells increases the sensitivity of ovarian cancer cells to docetaxel and taxane via a LAMC2‑mediated PI3K/Akt axis. International Journal of Molecular Medicine 46:2, pages 609-620.
Crossref
Crossref
Kevin DzoboCollet Dandara. (2020) Broadening Drug Design and Targets to Tumor Microenvironment? Cancer-Associated Fibroblast Marker Expression in Cancers and Relevance for Survival Outcomes. OMICS: A Journal of Integrative Biology 24:6, pages 340-351.
Crossref
Crossref
Nan Han, Udo Jeschke, Christina Kuhn, Anna Hester, Bastian Czogalla, Sven Mahner, Miriam Rottmann, Doris Mayr, Elisa Schmoeckel & Fabian Trillsch. (2020) H3K4me3 Is a Potential Mediator for Antiproliferative Effects of Calcitriol (1α,25(OH)2D3) in Ovarian Cancer Biology. International Journal of Molecular Sciences 21:6, pages 2151.
Crossref
Crossref
Hua Tian, Li Yan, Li Xiao-fei, Sun Hai-yan, Chen Juan & Kang Shan. (2019) Hypermethylation of mismatch repair gene hMSH2 associates with platinum-resistant disease in epithelial ovarian cancer. Clinical Epigenetics 11:1.
Crossref
Crossref
Wengong Si, Jiaying Shen, Huilin Zheng & Weimin Fan. (2019) The role and mechanisms of action of microRNAs in cancer drug resistance. Clinical Epigenetics 11:1.
Crossref
Crossref
Kevin Dzobo. (2019) Epigenomics-Guided Drug Development: Recent Advances in Solving the Cancer Treatment “jigsaw puzzle”. OMICS: A Journal of Integrative Biology 23:2, pages 70-85.
Crossref
Crossref
Leyla Norouzi-Barough, Mohammad Reza Sarookhani, Mohammadreza Sharifi, Sahar Moghbelinejad, Saranaz Jangjoo & Rasoul Salehi. (2018) Molecular mechanisms of drug resistance in ovarian cancer. Journal of Cellular Physiology 233:6, pages 4546-4562.
Crossref
Crossref
Shipeng Chen, Luo Yang & Jie Feng. (2018) Nitidine chloride inhibits proliferation and induces apoptosis in ovarian cancer cells by activating the Fas signalling pathway. Journal of Pharmacy and Pharmacology 70:6, pages 778-786.
Crossref
Crossref
Peter L Freddolino, Jamie Yang, Amir Momen-Roknabadi & Saeed Tavazoie. (2018) Stochastic tuning of gene expression enables cellular adaptation in the absence of pre-existing regulatory circuitry. eLife 7.
Crossref
Crossref
Di Wu, Pan Lu, Xue Mi & Jinwei Miao. (2018) Downregulation of miR-503 contributes to the development of drug resistance in ovarian cancer by targeting PI3K p85. Archives of Gynecology and Obstetrics 297:3, pages 699-707.
Crossref
Crossref
Mohammadreza Hajjari & Saghar Rahnama. (2017) HOTAIR Long Non-coding RNA: Characterizing the Locus Features by the In Silico Approaches. Genomics & Informatics 15:4, pages 170-177.
Crossref
Crossref
Daniel Kritsch, Franziska Hoffmann, Daniel Steinbach, Lars Jansen, Stella Mary Photini, Mieczyslaw Gajda, Alexander S. Mosig, Jürgen Sonnemann, Sven Peters, Margarita Melnikova, Jürgen Thomale, Matthias Dürst, Ingo B. Runnebaum & Norman Häfner. (2017) Tribbles 2 mediates cisplatin sensitivity and DNA damage response in epithelial ovarian cancer. International Journal of Cancer 141:8, pages 1600-1614.
Crossref
Crossref
Jinyun Li, Cheng Chen, Xuer Bi, Chongchang Zhou, Tao Huang, Chao Ni, Ping Yang, Si Chen, Meng Ye & Shiwei Duan. (2017) DNA methylation of CMTM3 , SSTR2 , and MDFI genes in colorectal cancer. Gene 630, pages 1-7.
Crossref
Crossref
Yankun Liu, Sugui Han, Yuhui Li, Yan Liu, Di Zhang, Yufeng Li & Jinghua Zhang. (2017) MicroRNA-20a contributes to cisplatin-resistance and migration of OVCAR3 ovarian cancer cell line. Oncology Letters 14:2, pages 1780-1786.
Crossref
Crossref
Mengxi Huang, Cheng Chen, Jian Geng, Dong Han, Tao Wang, Tao Xie, Liya Wang, Ye Wang, Chunhua Wang, Zengjie Lei & Xiaoyuan Chu. (2017) Targeting KDM1A attenuates Wnt/β-catenin signaling pathway to eliminate sorafenib-resistant stem-like cells in hepatocellular carcinoma. Cancer Letters 398, pages 12-21.
Crossref
Crossref
Xi Han, Shuai Zhen, Zhongxue Ye, Jiaojiao Lu, Lijie Wang, Pan Li, Jie Li, Xia Zheng, Huijin Li, Wei Chen, Le Zhao & Xu Li. (2017) A Feedback Loop Between miR-30a/c-5p and DNMT1 Mediates Cisplatin Resistance in Ovarian Cancer Cells. Cellular Physiology and Biochemistry 41:3, pages 973-986.
Crossref
Crossref
Xiaodi Li, Wei Chen, Wenshu Zeng, Chunling Wan, Shiwei Duan & Songshan Jiang. (2016) microRNA-137 promotes apoptosis in ovarian cancer cells via the regulation of XIAP. British Journal of Cancer 116:1, pages 66-76.
Crossref
Crossref
Benjamin Bonavida. 2017. Nitric Oxide as a Chemosensitizing Agent. Nitric Oxide as a Chemosensitizing Agent
15
34
.
Ewa M. Michalak & Jane E. Visvader. (2016) Dysregulation of histone methyltransferases in breast cancer – Opportunities for new targeted therapies?. Molecular Oncology 10:10, pages 1497-1515.
Crossref
Crossref